Community Acquired Pneumonia: 2019 New Guidelines Update

Dr. Olga Klinkova, Infectious Diseases Clinician at the Moffitt Cancer Center and Research Institute, discusses the recent updates to the diagnosis and management of community acquired pneumonia. Dr. Klinkova begins her talk by referring to the recently introduced IDSA-ATS guidelines, released in August, 2019. She then discusses updates in the microbiology of CAP, including the most likely organisms, the role of MRSA, atypicals and the significance of viral pathogens. She then mentions diagnostic modalities and the relevance of clinical prediction algorithms such as CURB-65 and the Pneumonia Severity Index (PSI). Treament considerations including outpatient versus inpatient, and inpatient non-severe versus inpatient severe management are also differentiated. Specific treatment agents and therapy durations are also mentioned. Lastly, she discusses options for the management of MRSA pneumonia and aspiration syndromes.
Stay in touch! Download our app on the iTunes store or find us below:
Subscribe to our CZcams Channel: / idpodcasts
Visit us on our webpage: www.idpodcasts.net
Follow us on Facebook: / id-podcasts-. .
Tweet to us: / idpodcasts

[@snsdad1ct]

Thank you so much for this update! I'm more of an oral learner so having someone present the information and telling me is much easier for me to learn than me reading through the guidelines and falling asleep every 5 mins haha

[@criticalcareeducationalsup4464]

Excellent review. Thanks

[@909One92]

Excellent summation. Did you have any talks on Bone and Joint or Skin and Soft Tissue Infection?

[@t14dann18]

This is so helpful

[@xDomglmao]

Excellent! A lecture about NPNA would be awesome!

[@nezarmohamed5850]

Very very excellent and skillful
Thanks a lot

[@nailuna2021]

Thanks

[@marwanwanis9496]

Thanx❤❤❤

[@artsychindiiMD]

Do you have updated soft copy cpg 2019?

[@davidmbeckmann]

I think the procalcitonin value is helpful for distinguishing viral from bacterial pneumonia . It makes no sense to treat more than half the patients, who have viruses, inappropriately with antibiotics? And I work in a community hospital, and 4 years as a hospitalist have never seen MRSA pneumonia.

[@ahmedthaer1202]

studies have shown that procalcitonin sensitivity ranges between 30 to 80 % so, not that great. Also, 2019 guidelines recommended that empiric antibiotic therapy should be initiated in adults with clinically suspected and radiographically confirmed CAP regardless of initial serum procalcitonin level

[@davidmbeckmann]

@@ahmedthaer1202 As if you can tell viral infections from bacterial clinically?! What a joke. " Studies have shone, " ugh...I see so many bullshit pneumonia admissions with no fever, no WBC, and chronic infiltrates and changes on CXR... an undetectable procalcitonin is helpful whether dear little you think so or not. Also, I do CT scans without contrast to rule out bogus pneumonia's. My life consists of having to tell COPD patients they don't have pneumonia, despite what the ED told them, CoVid, other viral, or bacterial.

[@ahmedthaer1202]

@@davidmbeckmann I'm still a medical students and I don't have much of an experience, I know not all the guidelines are being applied in hospitals ,but I'm just reporting what i read from the 2019 guidelines

[@davidmbeckmann]

@@ahmedthaer1202 Good, maybe then after 30 years of hospital practice you should comment. Good luck to you!

[@marcindec6158]

@@davidmbeckmann You're everything thats wrong with medical education and hierarchy in hospitals. I bet that those "30 years of practice" have been a shitty, not evidence based practice and your patients have suffered because of it. You're condescending and mean, I wish you all the worst.